BOURGEOIS Sandrine

BOURGEOIS Sandrine

Fonction : Maitre de conférence

Equipe : GEPHARM

Competence :

Formulation et caractérisation de systèmes micro- et nanoparticulaires à Encapsulation Formulation et caractérisations de formes solides

Bureau : G207

Téléphone : 04 72 43 18 35

e-mail : sandrine.bourgeois@univ-lyon1.fr M’envoyer un message

Spécialité :

Génie Pharmaceutique



25 documents

  • Camille Dumont, Sandrine Bourgeois, Hatem Fessi, Pierre-Yves Dugas, Vincent Jannin. In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract. International Journal of Pharmaceutics, Elsevier, 2019, 565, pp.409-418. ⟨10.1016/j.ijpharm.2019.05.037⟩. ⟨hal-02140441⟩
  • Laurent Ettouati, Zoé Senta-Loys, Sandrine Bourgeois, Bernard Fenet, Marc Le Borgne, et al.. Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation. Pharmaceutics, MDPI, 2019, 11 (1), pp.44. ⟨10.3390/pharmaceutics11010044⟩. ⟨hal-01987081⟩
  • Elie Akanny, Anne Bonhommé, Laurence Bois, Sylvain Minot, Sandrine Bourgeois, et al.. Development and Comparison of Surface-Enhanced Raman Scattering Gold Substrates for In Situ Characterization of ‘Model’ Analytes in Organic and Aqueous Media. Chemistry Africa, Springer, 2019, 2, pp.1-12. ⟨10.1007/s42250-019-00053-2⟩. ⟨hal-02119126⟩
  • Manon Lascol, Sandrine Bourgeois, C. Barratier, Pedro Marote, Pierre Lantéri, et al.. Development of pectin microparticles by using ionotropic gelation with chlorhexidine as cross-linking agent. International Journal of Pharmaceutics, Elsevier, 2018, 542 (1-2), pp.205 - 212. ⟨10.1016/j.ijpharm.2018.03.011⟩. ⟨hal-01744673⟩
  • Marion Dubald, Sandrine Bourgeois, Véronique Andrieu, Hatem Fessi. Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review. Molecular Pharmaceutics, American Chemical Society, 2018, 10 (1), ⟨10.3390/pharmaceutics10010010⟩. ⟨hal-01895937⟩
  • Z. Senta-Loÿs, S. Bourgeois, S. Briançon, H. Fessi. Characterization and stability study of tetrabenazine loaded in orodispersible films for pediatric therapy. International Journal of Pharmaceutics, Elsevier, 2018, 536 (2), pp.503-504. ⟨10.1016/j.ijpharm.2017.08.029⟩. ⟨hal-01950971⟩
  • Marion Dubald, Sandrine Bourgeois, Veronique Andrieu, Hatem Fessi. Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review. Pharmaceutics, MDPI, 2018, 10 (1), pp.10. ⟨10.3390/pharmaceutics10010010⟩. ⟨hal-01858934⟩
  • Marion Dubald, Sandrine Bourgeois, Véronique Andrieu, Hatem Fessi. Ophthalmic Drug Delivery Systems for Antibiotherapy\textemdashA Review. Pharmaceutics, 2018, 10 (1), pp.10. ⟨hal-02014155⟩
  • Zoé Senta-Loys, Sandrine Bourgeois, Cyril Pailler-Mattei, Géraldine Agusti, Stéphanie Briançon, et al.. Formulation of orodispersible films for paediatric therapy: investigation of feasibility and stability for tetrabenazine as drug model. Journal of Pharmacy and Pharmacology, 2017. ⟨hal-02044589⟩
  • Zoé Senta-Loys, Sandrine Bourgeois, Jean-Pierre Valour, Stéphanie Briançon, Hatem Fessi. Orodispersible films based on amorphous solid dispersions of tetrabenazine. International Journal of Pharmaceutics, Elsevier, 2017, 518 (1-2), pp.242-252. ⟨hal-02014157⟩